Journal: The Journal of Biological Chemistry
Article Title: Periosteum-derived podoplanin-expressing stromal cells regulate nascent vascularization during epiphyseal marrow development
doi: 10.1016/j.jbc.2022.101833
Figure Lengend Snippet: Notch pathway regulates gene expression of basement membrane-related collagenous ECMs in PDPN-expressing SSC progenies. A , strategy for experiments involving the xenovascular model and LY-411575, a Notch pathway inhibitor. Prior to their coculture with HUVECs, PDPN-expressing SSC progenies were pretreated with LY-411575 in vitro . Isolated PDPN-expressing SSC progenies were subjected to ECM transcript analysis. B – F , LY-411575 suppresses the basement membrane ECM upregulation of PDPN-expressing SSC progenies during cell–cell interactions with HUVECs. In this experiment, we targeted the ECM genes Col4a1 ( B ), Col4a2 ( C ), Lama5 ( D ), Nid1 ( E ), and Nid2 ( F ), which were altered during coculture with HUVECs. G – L , RT-qPCR evaluating the expression of the genes encoding proteins present in vascular basement membrane-related ECMs under Notch stimulation with recombinant Notch ligands. ( G ) All recombinant Notch ligands upregulated Hes1 expression. The expression levels of collagenous or noncollagenous basement membrane ECMs genes: type IV collagen alpha-chains Col4a1 ( H ) and Col4a2 ( I ) laminin alpha-chains lama5 ( J ), and nidogen isoforms Nid1 ( K ) and Nid2 (L). ∗ p < 0.01 . ∗∗ p < 0.01 . ∗∗∗ p < 0.01 . ∗∗∗∗ p < 0.0001 . N.S. indicates nonsignificance differences. For panel B – F , comparison between two groups was performed by the Student’s t test (n = 5 per group). For panel G – L , multi-group comparison was performed by one-way ANOVA and Dunnett’s t test (n = 5 per group, control group: Fc). The error bars represent SEMs. ECM, extracellular matrix; HUVECs, human umbilical vein endothelial cells PDPN, podoplanin; RT-qPCR, reverse transcribed-quantitative PCR; SSC, skeletal stem cell.
Article Snippet: Recombinant Notch ligand-IgG Fc fusion proteins (JAG1-Fc, JAG2-Fc, DLL1-Fc, and DLL4-Fc) or recombinant human IgG1 Fc (Fc) were obtained from R&D Systems.
Techniques: Expressing, Membrane, In Vitro, Isolation, Quantitative RT-PCR, Recombinant, Comparison, Reverse Transcription, Real-time Polymerase Chain Reaction